BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 118 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $292,000 | -4.6% | 14,359 | +42.5% | 0.08% | -8.4% |
| Q3 2021 | $306,000 | +11.3% | 10,073 | +6.3% | 0.08% | +6.4% |
| Q2 2021 | $275,000 | -26.9% | 9,479 | +8.8% | 0.08% | -32.2% |
| Q1 2021 | $376,000 | +7.7% | 8,709 | +15.4% | 0.12% | +4.5% |
| Q4 2020 | $349,000 | +23.3% | 7,549 | +15.6% | 0.11% | +5.8% |
| Q3 2020 | $283,000 | -5.0% | 6,529 | +16.2% | 0.10% | -11.9% |
| Q2 2020 | $298,000 | – | 5,619 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
| XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
| Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
| AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
| Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
| SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
| Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
| Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |